Chemical, Structural, Clinical and Biological details of Antiviral agents ID: DrugRepV_7802



Chemical Information
Antiviral agent IDDrugRepV_7802
Antiviral agent nameBetulinic acid Drug Bank
IUPAC Name(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid PubChem
SMILES (canonical)CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C(=O)O PubChem
SMILES (isomeric)CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C(=O)O PubChem
Molecular FormulaC30H48O3 PubChem
Molecular Weight (g/mol)456.7 PubChem
InChlInChI=1S/C30H48O3/c1-18(2)19-10-15-30(25(32)33)17-16-28(6)20(24(19)30)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h19-24,31H,1,8-17H2,2-7H3,(H,32,33)/t19-,20+,21-,22+,23-,24+,27-,28+,29+,30-/m0/s1 PubChem
Common NameBetulic acid Drug Bank
Synonymsbetulinic acid | 472-15-1 | Mairin | Betulic acid | als-357
Structural Information
  
Clinical Information
Primary Indication (Clinical trial phases)Investigational Drug Bank
Biological Information
Primary Indication (Disease Category) Non Infectious Disease
Primary Indication (Disease)Dysplastic Nevus Syndrome
Secondary Indication Severe acute respiratory syndrome coronavirus (SARS-CoV) NA NAWorld Health OrganisationCDC
Secondary Indication (Approaches)Experimental
Secondary Indication (Methods)In-vitro
Secondary Indication (Model system) [cell lines/ animal models]Vero E6 cells
Secondary Indication (Mode of viral infection)Adsorption
Secondary Indication (Mode of drug delivery) Culture
Secondary Indication (Drug concentration)>10 μM
Secondary Indication (Change)Decrease
Secondary Indication (Type of Inhibition) EC50 [ 50 % ]
Secondary Indication (Cytotoxicity)150 μM
ReferenceWen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG, Lee CK, Chang ST, Kuo CJ, Lee SS, Hou CC, Hsiao PW, Chien SC, Shyur LF, Yang NS..Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus..J Med Chem. 2007 Aug 23;50(17):4087-95. doi: 10.1021/jm070295s. PMID:17663539 PubMed
CommentSpecific abietane-type diterpenoids and lignoids exhibit strong anti-SARS-CoV effects